1. |
苏静, 应建明, 刘业强, 等. 黑色素瘤病理诊断临床实践指南(2021版)[J]. 中华病理学杂志, 2021, 50(6): 572-582. DOI: 10.3760/cma.j.cn112151-20210417-00299.Su J, Ying JM, Liu YQ, et al. Chinese guidelines on standardized pathological diagnosis of melanoma(2021 version)[J]. Chin J Pathol, 2021, 50(6): 572-582. DOI: 10.3760/cma.j.cn112151-20210417-00299.
|
2. |
中国医药教育协会眼科专业委员会, 中华医学会眼科学分会眼整形眼眶病学组, 中国抗癌协会眼肿瘤专业委员会. 中国葡萄膜黑色素瘤诊疗专家共识(2021年)[J]. 中华眼科杂志, 2021, 57(12): 886-897. DOI: 10.3760/cma.j.cn112142-20210926-00452.Ophthalmological Society of China Medicine Education Association, Oculoplastic and Orbital Disease Group of Chinese Ophthalmological Society of Chinese Medical Association, Ocular Oncology Committee of China Anti-Cancer Association. Chinese expert consensus on diagnosis and treatment of uveal melanoma (2021)[J]. Chin J Ophthalmol, 2021, 57(12): 886-897. DOI: 10.3760/cma.j.cn112142-20210926-00452.
|
3. |
Shields CL, Kels JG, Shields JA. Melanoma of the eye: revealing hidden secrets, one at a time[J]. Clin Dermatol, 2015, 33(2): 183-196. DOI: 10.1016/j.clindermatol.2014.10.010.
|
4. |
Smit KN, Jager MJ, de Klein A, et al. Uveal melanoma: towards a molecular understanding[J/OL]. Prog Retin Eye Res, 2020, 75: 100800[2019-09-26]. https://pubmed.ncbi.nlm.nih.gov/31563544/. DOI: 10.1016/j.preteyeres.2019.100800.
|
5. |
Li Y, Jia R, Ge S. Role of epigenetics in uveal melanoma[J]. Int J Biol Sci, 2017, 13(4): 426-433. DOI: 10.7150/ijbs.18331.
|
6. |
Chai P, Yu J, Jia R, et al. Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis[J]. Nucleic Acids Res, 2020, 48(21): 12135-12150. DOI: 10.1093/nar/gkaa1051.
|
7. |
Vader MJC, Madigan MC, Versluis M, et al. GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi[J]. Br J Cancer, 2017, 117(6): 884-887. DOI: 10.1038/bjc.2017.259.
|
8. |
Pan H, Jia R, Zhang L, et al. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells[J]. Int J Biochem Cell Biol, 2015, 60: 176-184. DOI: 10.1016/j.biocel.2015.01.001.
|
9. |
Furney SJ, Pedersen M, Gentien D, et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma[J]. Cancer Discovery, 2013, 3(10): 1122-1129. DOI:10.1158/2159-8290.CD-13-0330.
|
10. |
Xing Y, Wen X, Ding X, et al. CANT1 lncRNA triggers efficient therapeutic efficacy by correcting aberrant incing cascade in malignant uveal melanoma[J]. Mol Ther, 2017, 25(5): 1209-1221. DOI: 10.1016/j.ymthe.2017.02.016.
|
11. |
张举, 魏文斌, 李彬, 等. 蕈伞形葡萄膜黑色素瘤的临床病理学特征分析[J]. 中华眼底病杂志, 2020, 36(2): 127-130. DOI: 10.3760/cma.j.issn.1005-1015.2020.02.008.Zhang J, Wei WB, Li B, et al. Clinical pathology analysis of patients with mushroom shaped uveal melanoma[J]. Chin J Ocul Fundus Dis, 2020, 36(2): 127-130. DOI: 10.3760/cma.j.issn.1005-1015.2020.02.008.
|
12. |
张举, 顼晓琳, 李彬, 等. 葡萄膜黑色素瘤瘤体生长对视网膜和巩膜浸润的影响[J]. 中华眼科杂志, 2016, 52(10): 749-754. DOI: 10.3760/cma.j.issn.0412-4081.2016.10.007.Zhang J, Xu XL, Li B, et al. Characteristics of retinal and scleral infiltration in uveal melanoma[J]. Chin J Ophthalmol, 2016, 52(10): 749-754. DOI: 10.3760/cma.j.issn.0412-4081.2016.10.007.
|
13. |
Manchegowda P, Singh AD, Shields C, et al. Uveal melanoma in Asians: a review[J]. Ocul Oncol Pathol, 2021, 7: 159-167. DOI: 10.1159/000512738.
|
14. |
崔红霞, 王超, 沈珊珊, 等. 肛管直肠恶性黑色素瘤14例临床病理学分析[J]. 中华病理学杂志, 2022, 51(7): 650-652. DOI: 10.3760/cma.j.cn112151-20210920-00690.Cui HX, Wang C, Shen SS, et al. Anorectal malignant melanoma: a clinicopathological analysis of fourteen cases[J]. Chin J Pathol, 2022, 51(7): 650-652. DOI: 10.3760/cma.j.cn112151-20210920-00690.
|
15. |
Si L, Kong Y, Xu X, et al. Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort[J]. Eur J Cancer, 2012, 48(1): 94-100. DOI: 10.1016/j.ejca.2011.06.056.
|
16. |
Cheng L, Lopez-Beltran A, Massari F, et al. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine[J]. Mod Pathol, 2018, 31(1): 24-38. DOI: 10.1038/modpathol.2017.104.
|
17. |
Wei X, Mao L, Chi Z, et al. Efficacy evaluation of Imatinib for the treatment of melanoma: evidence from a retrospective study[J]. Oncol Res, 2019, 27(4): 495-501. DOI: 10.3727/096504018X15331163433914.
|
18. |
Dummer R, Schadendorf D, Ascierto PA, et al. Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial[J]. Lancet Oncol, 2017, 18(4): 435-445. DOI: 10.1016/S1470-2045(17)30180-8.
|
19. |
Yordi S, Soto H, Bowen RC, et al. Photodynamic therapy for choroidal melanoma: what is the response rate?[J]. Surv Ophthalmol, 2021, 66(4): 552-559. DOI: 10.1016/j.survophthal.2020.09.006.
|